Quality assurance analysis of hippocampal avoidance in a melanoma whole brain radiotherapy randomized trial shows good compliance

Quality assurance analysis of hippocampal avoidance in a melanoma whole brain radiotherapy randomized trial shows good compliance

Abstract Background Melanoma brain metastases (MBM) often cause morbidity and mortality for stage IV melanoma patients. An ongoing randomised phase III trial (NCT01503827 – WBRT-Mel) evaluates the role of adjuvant whole brain radiotherapy (WBRT) following local treatment of MBM. Hippocampal avoidanc...

Full description

Bibliographic Details
Main Authors: Geoffrey Martinage, Angela M. Hong, Mike Fay, Thanuja Thachil, Daniel Roos, Narelle Williams, Serigne Lo, Gerald Fogarty
Format: Article
Language:English
Published: BMC 2018-07-01
Series:Radiation Oncology
Subjects:
Radiotherapy
Whole brain radiotherapy
Trial
Quality assurance
Intensity-modulated radiotherapy
Hippocampal avoidance
Online Access:http://link.springer.com/article/10.1186/s13014-018-1077-z

Internet

http://link.springer.com/article/10.1186/s13014-018-1077-z

Similar Items